Woman with previously diagnosed SCLC
Author and Disclosure Information [Show]

Karl J. D'Silva, MD, Clinical Assistant Professor, Department of Medicine, Tufts University School of Medicine, Boston; Medical Director, Department of Oncology and Hematology, Lahey Hospital and Medical Center, Peabody, Massachusetts

Karl J. D'Silva, MD, has disclosed no relevant financial relationships

Question 1 of 3

A 76-year-old African American woman with a history of stroke, hypertension, and diabetes presents for follow-up of small cell lung cancer (SCLC) with metastasis to the liver and bone. Her ECOG performance status is 2. She was treated with a combination of carboplatin and etoposide, with a partial response at 3 months.

What additional therapy could this patient be receiving?

Vascular endothelial growth factor A antagonist

Programmed death ligand 1 (PD-L1) blocking antibody

Kinase inhibitor


This quiz is not accredited for CME.

More from Case in Point: Lung Cancer


Fatigue and persistent cough
Fatigue and shoulder weakness
Fatigue, cough, and dyspnea
Recurrent fever and wheezing
40–pack-year smoking history
Man with dyspnea and chest pain
Chronic cough and lack of sleep
Man with coughing and bloody sputum